NPS Pharmaceuticals, Inc. (NPSP) Tops Q2 EPS by 2c
Get Alerts NPSP Hot Sheet
Price: $45.97 --0%
Financial Fact:
Loss before income tax expense: -1.93M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Loss before income tax expense: -1.93M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
NPS Pharmaceuticals, Inc. (NASDAQ: NPSP) reported Q2 EPS of $0.02, $0.02 better than the analyst estimate of $0.00. Revenue for the quarter came in at $56.13 million versus the consensus estimate of $53.06 million.
For earnings history and earnings-related data on NPS Pharmaceuticals, Inc. (NPSP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) tops Q1 EPS by 3c; misses on guidance
- Hub Group, Inc. (HUBG) Tops Q1 EPS by 5c, provides guidance
- KLA Corporation (KLAC) Tops Q3 EPS by 23c, Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!